ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "race/ethnicity"

  • Abstract Number: 0645 • ACR Convergence 2024

    Mortality and Ethnicity in Adults with Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Analysis

    Samir Patel1, Zijing Yang1, deepak Nagra1, Maryam Adas2, Mark Russell1, Sam Norton1, Chris Wincup3, James Galloway4, Kate Bramham2 and Patrick Gordon5, 1King's College London, London, England, United Kingdom, 2King's College London, London, United Kingdom, 3King's College Hospital, London, United Kingdom, 4Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 5nhs, London, United Kingdom

    Background/Purpose: Ethnicity and health outcomes are intrinsically interrelated, although mechanisms are complex. Systemic lupus erythematosus (SLE) is a disease with higher incidence in non-White populations…
  • Abstract Number: 1907 • ACR Convergence 2024

    Community-Engaged Curriculum Development Using Racial Justice and Biomedical Lenses to Address COVID-19 Vaccine Hesitancy in Black Individuals with Rheumatologic Conditions

    Eseosa Osaghae1, Greta Sirek2, Tonya Roberson3, Mia Chandler4, Ariel Childs5, Monica Crespo-Bosque6, Gina Curry7, Amar Dhand8, Mary Dollear9, Alice Eggleston10, Nnenna Ezeh2, Dieufort Fleurissaint11, Denice Garrett12, Gail Granville13, Muriel Jean-Jacques1, Elena Losina2, Holly Milaeger1, Lutfiyya Muhammad14, Mary Ann Nelson15, Chisa Nosamiefan16, Bisola Ojikutu17, Neil Pillai1, Marie Jacques Toussaint18, Mary Beth Son19, Ana Valle2, Jessica Williams20, Michael York21, Karen Mancera-Cuevas22, Candace Feldman2 and rosalind Ramsey-Goldman1, 1Northwestern University, Chicago, IL, 2Brigham and Women's Hospital, Boston, MA, 3Governors State University College of Health and Human Services, University Park, IL, 4Boston Children’s Hospital, Boston, MA, 5Vital CxNs, Boston, MA, 6Boston Medical Center, Boston, MA, 7University of Chicago Pritzker School of Medicine, Chicago, IL, 8Brigham and Women’s Hospital, Boston, MA, 9Lupus Society of Illinois, Chicago, IL, 10Alliance Chicago, Chicago, IL, 11True Alliance Center, Inc, Boston, MA, 12Action for Bridgeport Community Development, Inc., Bridgeport, CT, 13Women of Courage, Inc, Boston, MA, 14Northwestern Feinberg School of Medicine, Chicago, IL, 15Mission Hill Health Movement Inc, Roxbury, MA, 16The Labalaba Foundation for Lupus Awareness and Advocacy, South Weymouth, MA, 17Harvard Medical School, Brigham and Women’s Hospital, Boston Public Health Commission,, Boston, MA, 18True Alliance Center, Inc., Boston, MA, 19Boston Children's Hospital, Brookline, MA, 20Emory School of Medicine, Atlanta, GA, 21Boston University, Boston, MA, 22National Health Council, Washington, DC

    Background/Purpose: Despite the efficacy of COVID-19 vaccines and the benefits for individuals with rheumatic conditions, racial inequities in uptake persist. We initiated a trial that…
  • Abstract Number: 0847 • ACR Convergence 2024

    Sex and Race-Specific Distributions in Medial Fixed Joint Space Width in Healthy Knees from Three Longitudinal Cohorts

    Kent Kwoh1, Rongrong Tang2, Erin Ashbeck3, Edward Bedrick4, Yvonne Golightly5, Amanda Nelson6, Tuhina Neogi7, Yong Ge8, Zong-Ming Li2, Jean Liew7, Xiaoxiao Sun9, Justin Crawmer10 and Jeffery Duryea11, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, University of Arizona College of Medicine - Tucson, Tucson, AZ, 3University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, 4Department of Epidemiology andBiostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, 5University of Nebraska Medical Center, Omaha, NE, 6University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 8Department of Information Sciences, Eller College of Manangement, University of Arizona, Tucson, AZ, 9Department of Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 10BWH, Boston, MA, 11Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Quantitative radiographic joint space width (JSW)  is often used as ameasure of structural outcomes in randomized controlled trials of knee OA (KOA). How JSW…
  • Abstract Number: 1914 • ACR Convergence 2024

    Racial and Ethnic Differences in the Prevalence of Disease Features in Systemic Sclerosis

    Harry Hurley1, Davina Chen2, Xianhong Xie3, Manpreet Parmar4 and Bibi Ayesha5, 1Albert Einstein College of Medicine, Maplewood, NJ, 2Montefiore Medical Center, New Rochelle, NY, 3Albert Einstein College of Medicine, Bronx, NY, 4Montefiore, Bronx, NY, 5Montefiore Medical Center, Metuchen, NJ

    Background/Purpose: Systemic sclerosis (SSc) is a chronic, systemic autoimmune disease with a higher prevalence among women and racial/ethnic minority groups in the US. Despite the…
  • Abstract Number: 0115 • ACR Convergence 2024

    Regional and Ethnoracial Differences Among Antiphospholipid Antibody-Positive Patients with No Other Systemic Autoimmune Rheumatic Diseases: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Registry

    Elena Gkrouzman1, Ann E. Clarke2, Maria Tektonidou3, Vittorio Pengo4, Savino Sciascia5, Jose Pardos-Gea6, Nina Kello7, Diana Paredes-Ruiz8, Mª Angeles Aguirre-Zamorano9, H Michael Belmont10, Paul Fortin11, Guilherme Ramires de Jesús12, Tatsuya Atsumi13, Zhuoli Zhang14, Maria Efthymiou15, David Branch16, Giulia Pazzola17, Laura Andreoli18, Ali Duarte-Garcia19, Esther Rodriguez-Almaraz20, Michelle Petri21, Ricard Cervera22, Bahar Artim Esen23, Guillermo Pons-Estel24, Hui Shi25, Jason Knight26, Rohan Willis27, Pierluigi Meroni28, Maria Laura Bertolaccini29, Hannah Cohen30, Robert Roubey31, Danieli Andrade32 and Doruk Erkan33, and on behalf of APS ACTION, 1University of Massachusetts, Westborough, MA, 2Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3National and Kapodistrian University of Athens, Athens, Greece, 4Thrombosis Research Laboratory, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy, 5University of Turin, Torino, Turin, Italy, 6Vall d'Hebron University Hospital, Barcelona, Spain, 7Northwell Health, Brooklyn, NY, 8Autoimmune Diseases Research Unit. Biocruces Bizkaia Health Research Institute, Baracaldo, Spain, 9IMIBIC/Reina Sofia Hospital/University of Cordoba, CÓRDOBA, Andalucia, Spain, 10NYU School of Medicine, New York, NY, 11Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 12Universidade do Estado do Rio de Janeiro, Rio De Janeiro, Brazil, 13Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, Sapporo, Japan, 14Peking University First Hospital, Beijing, China, 15University College London, London, United Kingdom, 16University of Utah and Intermountain Healthcare, Salt Lake City, UT, 17Rheumatology Unit, Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy, 18University of Brescia, Brescia, Italy, 19Mayo Clinic, Rochester, MN, 20Hospital Universitario 12 de Octubre, Madrid, Spain, 21Johns Hopkins University School of Medicine, Timonium, MD, 22Hospital Clinic de Barcelona, Barcelona, Spain, 23Istanbul University, Istanbul Faculty of Medicine, Division of Rheumatology, Istanbul, Turkey, 24CREAR, Rosario, Argentina, 25Department of Rheumatology and lmmunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China (People's Republic), 26University of Michigan, Ann Arbor, MI, 27University of Texas Medical Branch, Galveston, TX, 28IRCCS Istituto Auxologico Italiano 100%, Cusano Milanino, Milan, Milan, Italy, 29King's College London, London, United Kingdom, 30University College London Hospitals NHS Foundation Trust, London, United Kingdom, 31Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, 32University of São Paulo, São Paulo, SP, Brazil, 33Hospital for Special Surgery, New York, NY

    Background/Purpose: The APS ACTION Registry was created to study long-term outcomes in persistently antiphospholipid antibody (aPL)-positive patients with and without other systemic autoimmune rheumatic diseases…
  • Abstract Number: 0976 • ACR Convergence 2024

    Assessment of Current Trends in Demographic and Clinical Characteristics of Male Patients with Rheumatoid Arthritis in North India

    BHARAT KUMAR SINGH1 and Seema Singh2, 1CK Birla Hospitals, Jaipur, JAIPUR, Rajasthan, India, 2RAJASTHAN UNIVERSITY OF HEALTH SCIENCES, JAIPUR, Rajasthan, India

    Background/Purpose: Gender differences in rheumatoid arthritis (RA) are well-established, with women more prone to developing RA than men. However, understanding the impact of gender on…
  • Abstract Number: 1915 • ACR Convergence 2024

    Patient-reported Difficulties Regarding Reproductive Health Discussions in an Urban Outpatient Setting

    Martha Delgado1, Cassidy Hernandez-Tamayo2, Melissa Wilson2 and Leanna Wise3, 1Los Angeles General Hospital/Keck Medicine of USC, Costa Mesa, CA, 2Keck School of Medicine of USC, Los Angeles, CA, 3LAGMC/Keck Medicine of USC, Los Angeles, CA

    Background/Purpose: Timely reproductive health conversations in the rheumatology outpatient setting are essential for optimal maternal-fetal health; however, the literature suggests that these conversations happen for…
  • Abstract Number: 0144 • ACR Convergence 2024

    More Than a Monolith: Disaggregating Rheumatoid Arthritis Prevalence Among Asian American Subgroups

    John Chen1, Tanya Selvam1, Jeanne Darbinian2, Christopher Macko1, Nirmala Ramalingam2, Joan Lo2 and Lucy Liu2, 1Kaiser Permanente Oakland Medical Center, Oakland, CA, 2Kaiser Permanente, Oakland, CA

    Background/Purpose: Rheumatoid arthritis (RA) is a disabling, autoimmune condition affecting up to as many as 17.6 million individuals worldwide. Epidemiologic evidence in the United States…
  • Abstract Number: 0993 • ACR Convergence 2024

    Pulmonary Complications and Mortality Trends in Rheumatoid Arthritis Patients Aged 65 and Older in the United States: A CDC WONDER Database Analysis

    Muhammad Naveed1, Rabia Iqbal1, Kishan Patel2, Ahila Ali1, Simran Bhimani3, Bazil Azeem4, Yash Deshpande3, Muhammad Omer Rehan1, Faizan Ahmed5, Hussain Haider Shah1 and Nouman Shafique6, 1Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan, 2Riverside Community Hospital, Riverside, CA, 3The Wright Center for graduate medical education, Scranton, PA, 4Shaheed Mohtarma Benazir Bhutto Medical College Liyari, Karachi, Pakistan, 5Ameer-ud-Din Medical College, Lahore, Pakistan, 6AdventHealth Orlando, Orlando, FL

    Background/Purpose: Pulmonary complications in rheumatoid arthritis (RA) are an important cause of mortality among older adults. This study analyzes trends and demographic disparities in mortality…
  • Abstract Number: 1920 • ACR Convergence 2024

    Admixture Mapping and Gene-Based Analysis Identifies Rare Variants in Genes in the IL-13 and TGFβ Signaling Pathways in African Americans with Systemic Sclerosis

    Jordan Hicks1, Daniel Shriner2, Ami Shah3, Maureen Mayes4, Ayo P. Doumatey2, Amy R. Bentley1, Robyn Domsic5, Thomas Medsger, Jr6, Paula Ramos7, Richard Silver8, Virginia Steen9, John Varga10, Vivien Hsu11, Lesley Ann Saketkoo12, Dinesh Khanna10, Elena Schiopu13, Jessica Gordon14, Lindsey Criswell15, Heather Gladue16, Chris Derk17, Elana Bernstein18, S. Louis Bridges14, Victoria Shanmugam19, Lorinda Chung20, Suzanne Kafaja21, Reem Jan22, Marcin Trojanowski23, Avram Goldberg24, Benjamin Korman25, James W. Thomas26, Elaine Remmers27, Adebowale Adeyemo2, Charles Rotimi2, Fredrick Wigley28, Francesco Boin29, Daniel Kastner30 and Pravitt Gourh31, 1National institute of Health, Bethesda, MD, 2Center for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 3Division of Rheumatology, Johns Hopkins University, Ellicott City, MD, 4UTHealth Houston Division of Rheumatology, Houston, TX, 5Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Verona, PA, 7Medical University of South Carolina, Charleston, SC, 8Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, 9Georgetown University School of Medicine, Washington, DC, 10University of Michigan, Ann Arbor, MI, 11Department of Medicine, Rheumatology Division, Rutgers-RWJ Medical School, South Plainfield, NJ, 12New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University and Tulane University Medical Schools, New Orleans, LA, 13Division of Rheumatology, Medical College of Georgia at Augusta University, Martinez, GA, 14Division of Rheumatology, Weill Cornell Medical College, New York, NY, 15Genomics of Autoimmune Rheumatic Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, Bethesda, MD, 16Arthritis & Osteoporosis Consultants of the Carolinas, Charlotte, NC, 17Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 18Division of Rheumatology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 19NIH Office of Autoimmune Disease Research in the Office of Research on Women's Health, National Institutes of Health, Bethesda, MD, Bethesda, MD, 20Stanford University, Woodside, CA, 21Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, 22Section of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL, 23Department of Rheumatology, Boston University School of Medicine, Boston, MA, 24NYU Langone Health - NYU Hospital for Joint Diseases, Lake Success, NY, 25University of Rochester, Rochester, NY, 26NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 27Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 28Johns Hopkins University, Division of Rheumatology, Baltimore, MD, Baltimore, MD, 29Cedars-Sinai Medical Center, Los Angeles, CA, 30National Human Genome Research Institute, Bethesda, MD, 31National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, Bethesda, MD

    Background/Purpose: There are significant racial disparities in systemic sclerosis (SSc), with an increased disease burden and worse outcomes among African American (AA) individuals. Reasons for…
  • Abstract Number: 0174 • ACR Convergence 2024

    A Nationwide Analysis of Gender and Racial Disparities in Patients with Systemic Sclerosis and Acute Coronary Syndrome

    Omair Khan1, Kundan Jana2, Azka Naeem2, Syed Mujtaba Baqir2, Marlon Rivera Boadla2, Muhammad Hashim khan2 and Vijay Shetty2, 1Maimonides Medical Center, Council Bluffs, IA, 2Maimonides Medical Center, Brooklyn, NY

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune condition characterized by widespread skin fibrosis and/or end-organ damage. Previous studies have reported variable outcomes of the disease…
  • Abstract Number: 1016 • ACR Convergence 2024

    Pharmacoequity of DMARDs Among Adults with Rheumatoid Arthritis in the U.S

    Ashkan Ara1, Matthew Chenoweth2, Srikanth Kadiyala2, Utibe Essien3 and Christopher Scannell3, 1Division of Rheumatology, David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, 2Department of Health Policy and Management, Fielding School of Public Health at UCLA, Los Angeles, 3Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles

    Background/Purpose: Long-term management of rheumatoid arthritis (RA) relies on disease-modifying antirheumatic drugs (DMARDs), including conventional synthetic (csDMARDs), biologic (bDMARDs), and targeted synthetic (tsDMARDs). About 40%…
  • Abstract Number: 1921 • ACR Convergence 2024

    Devastating Morbidity and Mortality Rates in the Hmong Population with a Diagnosis of Gout Who Had a COVID-19 Infection

    Kari Falaas1, Michael Schnaus2, Margaret Singer3, Allison Hochstetler3, Pang Nhia Khang4, Katherine Schmiechen4 and Elie Gertner3, 1University of Minnesota, Regions Hospital, Minneapolis, MN, 2University of Minnesota, Regions Hospital, Methodist Hospital, Minneapolis, 3University of Minnesota, Regions Hospital, Minneapolis, 4Regions Hospital, Minneapolis

    Background/Purpose: Hyperuricemia is associated with an elevated risk of developing cardiovascular diseases, diabetes, chronic kidney disease, and metabolic syndromes. The Hmong population, in particular, has…
  • Abstract Number: 0176 • ACR Convergence 2024

    Race-Based Differences in Immune Responses Following an Episode of Acute Low Back Pain Among Those Who Develop Chronic LBP and Those Who Do Not

    Colleen Burke1, Michael Brown2, Rebecca Fillipo3, Stephanie Danyluk2, Kelley Seebeck2 and Adam Goode2, 1Duke University School of Medicine, Chapel Hill, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Durham, NC

    Background/Purpose: Acute low back pain (LBP) affects over 25% of adults annually in the United States, and as many as one-third of these individuals will…
  • Abstract Number: 1030 • ACR Convergence 2024

    Diversity in Axial Spondyloarthritis Drug Trials: Examining Enrollment by Sex, Race, Ethnicity and Geographic Region

    Mathieu Choufani1, Wissam Ghusn2 and Joerg Ermann3, 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, 2Department of Internal Medicine, Boston Medical Center, Boston, MA, 3Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: While axial spondyloarthritis (AxSpA) was historically perceived as a "white man's disease", it is now appreciated as a condition that can affect individuals of…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology